Anti‐thymocyte globulin improves survival free from relapse and graft‐versus‐host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia‐negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT

Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2IkuIyz
via IFTTT